These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1761736

  • 1. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
    Ohashi K, Sakamoto K, Sudo T, Tateishi T, Harada K, Fujimura A, Ebihara A, Tanaka E.
    J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
    [Abstract] [Full Text] [Related]

  • 2. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H, Kobayashi S, Hamada K, Iida S, Akita H, Tanaka E, Uchida E, Yasuhara H.
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [Abstract] [Full Text] [Related]

  • 3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR, Egan JM, Dickinson TH, Carrum G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
    Tanaka E, Nakamura K.
    Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
    [Abstract] [Full Text] [Related]

  • 7. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
    Tanaka E, Nakamura K.
    Eur J Clin Pharmacol; 1989 Aug; 36(6):629-32. PubMed ID: 2776822
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E, Kobayashi S, Aramphongphan A, Kurata N, Oguchi K, Kuroiwa Y, Yasuhara H.
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D, Blevins R, Kerner N, Rubenfire M, Edwards DJ.
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
    Anadón A, Martinez-Larrañaga MR, Fernandez MC, Diaz MJ, Bringas P.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.
    Badiola N, Al-Angary AN, Halbert GW.
    J Pharm Pharmacol; 1992 Apr; 44(4):366-8. PubMed ID: 1355554
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.